579 related articles for article (PubMed ID: 30598170)
1. Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome.
Talaulikar VS; Conway GS; Pimblett A; Davies MC
Fertil Steril; 2019 Mar; 111(3):505-509. PubMed ID: 30598170
[TBL] [Abstract][Full Text] [Related]
2. Bypassing physiological puberty, a novel procedure of oocyte cryopreservation at age 7: a case report and review of the literature.
Azem F; Brener A; Malinger G; Reches A; Many A; Yogev Y; Lebenthal Y
Fertil Steril; 2020 Aug; 114(2):374-378. PubMed ID: 32386868
[TBL] [Abstract][Full Text] [Related]
3. Should we perform oocyte accumulation to preserve fertility in women with Turner syndrome? A multicenter study and systematic review of the literature.
Brouillet S; Ranisavljevic N; Sonigo C; Haquet E; Bringer-Deutsch S; Loup-Cabaniols V; Hamamah S; Willems M; Anahory T
Hum Reprod; 2023 Sep; 38(9):1733-1745. PubMed ID: 37381072
[TBL] [Abstract][Full Text] [Related]
4. Characterization of follicles in girls and young women with Turner syndrome who underwent ovarian tissue cryopreservation.
Mamsen LS; Charkiewicz K; Anderson RA; Telfer EE; McLaughlin M; Kelsey TW; Kristensen SG; Gook DA; Ernst E; Andersen CY
Fertil Steril; 2019 Jun; 111(6):1217-1225.e3. PubMed ID: 30922638
[TBL] [Abstract][Full Text] [Related]
5. DuoStim: a new option for fertility preservation for a woman with Turner syndrome.
Ito A; Katagiri Y; Tamaki Y; Fukuda Y; Oji A; Morita M
Gynecol Endocrinol; 2020 Dec; 36(12):1144-1148. PubMed ID: 32945708
[TBL] [Abstract][Full Text] [Related]
6. Oocyte cryopreservation for fertility preservation in postpubertal female children at risk for premature ovarian failure due to accelerated follicle loss in Turner syndrome or cancer treatments.
Oktay K; Bedoschi G
J Pediatr Adolesc Gynecol; 2014 Dec; 27(6):342-6. PubMed ID: 25214440
[TBL] [Abstract][Full Text] [Related]
7. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
Domingo J; Guillén V; Ayllón Y; Martínez M; Muñoz E; Pellicer A; Garcia-Velasco JA
Fertil Steril; 2012 Apr; 97(4):930-4. PubMed ID: 22283969
[TBL] [Abstract][Full Text] [Related]
8. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
[TBL] [Abstract][Full Text] [Related]
9. Fertility preservation by ovarian stimulation and oocyte cryopreservation in a 14-year-old adolescent with Turner syndrome mosaicism and impending premature ovarian failure.
Oktay K; Rodriguez-Wallberg KA; Sahin G
Fertil Steril; 2010 Jul; 94(2):753.e15-9. PubMed ID: 20188362
[TBL] [Abstract][Full Text] [Related]
10. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
Reichman DE; Davis OK; Zaninovic N; Rosenwaks Z; Goldschlag DE
Fertil Steril; 2012 Nov; 98(5):1225-8. PubMed ID: 22884018
[TBL] [Abstract][Full Text] [Related]
11. Oocyte cryopreservation in a woman with mosaic Turner syndrome: a case report.
Kavoussi SK; Fisseha S; Smith YR; Smith GD; Christman GM; Gago LA
J Reprod Med; 2008 Mar; 53(3):223-6. PubMed ID: 18441731
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
[TBL] [Abstract][Full Text] [Related]
13. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
[TBL] [Abstract][Full Text] [Related]
14. The indication for fertility preservation in women with Turner syndrome should not only be based on the ovarian reserve but also on the genotype and expected future health status.
Nawroth F; Schüring AN; von Wolff M
Acta Obstet Gynecol Scand; 2020 Dec; 99(12):1579-1583. PubMed ID: 32860418
[TBL] [Abstract][Full Text] [Related]
15. Oocyte cryopreservation after controlled ovarian hyperstimulation in mosaic Turner syndrome: another fertility preservation option in a dedicated UK clinic.
El-Shawarby SA; Sharif F; Conway G; Serhal P; Davies M
BJOG; 2010 Jan; 117(2):234-7. PubMed ID: 20002398
[No Abstract] [Full Text] [Related]
16. Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?
Burks HR; Ross L; Opper N; Paulson E; Stanczyk FZ; Chung K
Fertil Steril; 2015 Sep; 104(3):643-8. PubMed ID: 26158904
[TBL] [Abstract][Full Text] [Related]
17. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
[TBL] [Abstract][Full Text] [Related]
18. Fertility preservation in childhood and adolescent female tumor survivors.
Filippi F; Meazza C; Somigliana E; Podda M; Dallagiovanna C; Massimino M; Raspagliesi F; Terenziani M
Fertil Steril; 2021 Oct; 116(4):1087-1095. PubMed ID: 34238574
[TBL] [Abstract][Full Text] [Related]
19. Cryopreservation of a mother's oocytes for possible future use by her daughter with Turner syndrome: case report.
Gidoni YS; Takefman J; Holzer HE; Elizur SE; Son WY; Chian RC; Tan SL
Fertil Steril; 2008 Nov; 90(5):2008.e9-12. PubMed ID: 18692829
[TBL] [Abstract][Full Text] [Related]
20. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
Sermondade N; Sonigo C; Sifer C; Valtat S; Ziol M; Eustache F; Grynberg M
Fertil Steril; 2019 Feb; 111(2):357-362. PubMed ID: 30527837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
